Targeting UDP‐glucose dehydrogenase inhibits ovarian cancer growth and metastasis-Reference-Cited by-同舟云学术

Targeting UDP‐glucose dehydrogenase inhibits ovarian cancer growth and metastasis

Published:2020-09-07 Issue:20 Volume:24 Page:11883-11902
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Lin Li‐Hsun¹,Chou Hsiu‐Chuan²,Chang Shing‐Jyh³,Liao En‐Chi¹,Tsai Yi‐Ting¹,Wei Yu‐Shan¹,Chen Hsin‐Yi¹,Lin Meng‐Wei¹,Wang Yi‐Shiuan¹,Chien Yu‐An¹,Yu Xin‐Ru²,Chan Hong‐Lin¹⁴^ORCID

Affiliation:

1. Institute of Bioinformatics and Structural Biology National Tsing Hua University Hsinchu Taiwan

2. Institute of Analytical and Environmental Sciences National Tsing Hua University Hsinchu Taiwan

3. Department of Obstetrics and Gynecology Hsinchu MacKay Memorial Hospital Hsinchu Taiwan

4. Department of Medical Sciences National Tsing Hua University Hsinchu Taiwan

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.15808

Reference55 articles.

1. Ovarian Cancer Metastasis: Integrating insights from disparate model organisms

2. Ovarian Cancer Development and Metastasis

3. Tumor Metastasis: Molecular Insights and Evolving Paradigms

4. Emerging Biological Principles of Metastasis

5. Epithelial-Mesenchymal Transitions in Development and Disease

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UDP-6-glucose dehydrogenase in hormonally responsive breast cancers;2024-03-21

2. UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis;Cell Reports;2024-02

3. BIRC5 facilitates cisplatin‐chemoresistance in a m⁶A‐dependent manner in ovarian cancer;Cancer Medicine;2023-12-19

4. Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cells;Nature;2023-10-25

5. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer;Journal of Experimental & Clinical Cancer Research;2023-10-19